Condition
Cefazolin
Total Trials
4
Recruiting
1
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 4 (2)
Trial Status
Active Not Recruiting1
Recruiting1
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06426836Not ApplicableRecruiting
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
NCT07253805Active Not Recruiting
Plasma and Tissue Concentration of Cefazolin in Preoperative Prophylaxis in Patients Undergoing Bariatric Surgery
NCT05132829Phase 4Unknown
Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial
NCT01097148Phase 4Completed
Peri -and Postoperative Drug Therapy Schedules for Morbidly Obese Patients
Showing all 4 trials